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Introduction

T follicular helper (T FH
In this study, we used cKO mice doubly deficient for both Bcl6 and Blimp1 in T cells to delineate the respective roles of these two key factors in T FH cell differentiation and PD-1 gene expression. Our results indicate that Bcl6 promotes both T FH cell differentiation and PD-1 expression by pathways essentially independent of Blimp1.
Results and Discussion
T FH cells but not T FR cells are dependent on Bcl6 for their development.
To analyze T FH cell differentiation when both Bcl6 and Blimp1 were deleted specifically in T cells, we generated CD4-cre Bcl6 fl/fl Prdm1 fl/fl (dcKO) mice. These mice were healthy and T cell development was normal (data not shown). We immunized the mice with sheep red blood cells (SRBC), and after 14 days, analyzed T FH cells in spleen ( This article is protected by copyright. All rights reserved. 
A T-bet-dependent mechanism for the activation of PD-1 expression by Bcl6
We next sought to find the mechanism for how Bcl6, a transcriptional repressor, could promote Pdcd1 mRNA expression independent of Blimp1. One explanation is that Bcl6
represses the transcription of microRNAs that silence PD-1 expression [3] . We therefore tested the role of microRNAs in the induction of PD-1 by Bcl6, and found that Bcl6 RV could still up-regulate PD-1 in Dicer cKO T cells, which are unable to generate microRNAs (Supporting Information Fig. 5 ). We then sought other pathways. T-bet is a transcriptional
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repressor of PD-1 gene expression [20] , and Bcl6 is a negative regulator of T-bet [21] .
Therefore we wondered if a T-bet-Bcl6 pathway could play a role in PD-1 expression in CD4
T cells. We tested this idea by transducing primary mouse CD4 T cells with T-bet-expressing RV, with and without Bcl6 RV. As shown in Figure 3A , T-bet RV can significantly repress PD-1 expression compared to control RV, whereas addition of Bcl6 RV allows for PD-1 activation even in the presence of T-bet RV. To further investigate this pathway, we analyzed PD-1 expression in Tbx21 -/-(Tbx21 KO or T-bet-deficient) CD4 T cells and as expected, saw higher PD-1 in T-bet KO T cells compared to wild-type T cells (Fig. 3B) .
Notably, Bcl6 RV was able to strongly activate PD-1 expression in wild-type T cells (~50% increase in MFI) but Bcl6 RV was only able to activate PD-1 relatively weakly in T-bet KO T cells (~20% increase in MFI) (Fig. 3BC ). These data indicate that a major pathway for the upregulation of PD-1 expression by Bcl6 is by counteracting the repressive action of T-bet on PD-1 expression.
Concluding Remarks
In summary, we have clarified several aspects of Bcl6 control over T FH cell and T FR cell differentiation (see model in Supporting Information Fig. 6 ). Specifically, we have found that:
1) Blimp1 primarily represses T FH cell differentiation by acting on Bcl6, 2) Blimp1 represses T FR cell differentiation through both Bcl6-dependent and Bcl6-independent pathways and 3)
Bcl6 promotes PD-1 expression by a novel Blimp1-independent mechanism involving T-bet inhibition.
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Materials and Methods
Mice and immunizations
Bcl6 fl/fl mice [11] were backcrossed to CD4-cre transgenic mice [22] and the C57BL/6 strain for at least six generations and then crossed to Prdm1 fl/fl mice [23, 24] . Tbx21 -/-mice were obtained from Jackson labs. Mice were bred under specific pathogen-free conditions at the laboratory animal facility at IUSM and were handled according to protocols approved by the IUSM Animal Use and Care Committee. For immunization, mice were injected intraperitoneally (i.p.) with 1 x 10 9 SRBCs (Rockland Immunochemicals) and sacrificed at the indicated day.
Flow cytometry reagents
Anti-CXCR5 (2G8) and GL7 (GL7) Abs were from BD Biosciences. Fixable viability dye, anti-CD38 and anti-Foxp3 (FJK-16s) Abs were from eBioscience. Anti-CD4 (GK1.5), anti-B220 (RA3-6B2), anti-IgG1 (RMG1-1), anti-PD-1 (29F.1A12) were from Biolegend.
Cell staining for flow cytometry
After red blood cell lysis, total spleen cells were incubated with anti-mouse CD16/CD32 (BioXcell) for 5 minutes at RT, followed by surface staining for the indicated markers. For intracellular transcription factor staining, after surface markers were stained, cells were fixed and stained with antibodies against transcription factors by following Foxp3 fixation kit This article is protected by copyright. All rights reserved.
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(eBioscience) instructions. Cell events were collected on an LSRII flow cytometer (Becton Dickonson).
Cell culture and retrovirus transduction CD4 T cells were isolated from the spleen via isolation kit (Miltenyi Biotec). Cells were activated with plate-bound anti-CD3 (10 μg/ml; 145-2C11; Bio XCell) and anti-CD28 (10 μg/ml; 37.51; Bio XCell) for 24 h at 1 X 10 6 cells/ml. Cells were then spin-infected with control GFP, Bcl6-GFP-expressing [25] retroviruses (RVs). For co-infection experiments, either control H2K k or Bcl6-H2K k -expressing [26] RVs were co-transduced with either control GFP or T-bet-GFP-expressing [27] RVs. After infection, supernatants were substituted with fresh medium containing 10 U/ml recombinant human IL-2. Two days later, cells were collected for analysis.
RT-QPCR and Antigen-specific IgG Analysis
These procedures were performed as previously reported [28] .
Statistical Analysis.
All data analysis was done using Prism Graphpad software. 
